CEVR (@tuftscevr) 's Twitter Profile
CEVR

@tuftscevr

Center for the Evaluation of Value & Risk in Health (CEVR) at @TuftsMedicalCtr. Postings and RTs are not endorsements.

ID: 563011611

linkhttps://cevr.tuftsmedicalcenter.org/ calendar_today25-04-2012 14:35:09

4,4K Tweet

2,2K Followers

2,2K Following

CEVR (@tuftscevr) 's Twitter Profile Photo

Eager to learn about new #CEA methods from leading scientists? Join Anirban Basu, Darius Lakdawalla, Melanie Whittington, and Beth Woods for Panel 3 at 10/26 Tufts-CEVR / Duke Margolis Symposium. Register now: In Person: eventbrite.com/e/tufts-cevrdu… Webinar: wellforce.zoom.us/webinar/regist…

Eager to learn about new #CEA methods from leading scientists? Join Anirban Basu, Darius Lakdawalla, Melanie Whittington, and Beth Woods for Panel 3 at 10/26 Tufts-CEVR / Duke Margolis Symposium.

Register now:

In Person: eventbrite.com/e/tufts-cevrdu…
Webinar: wellforce.zoom.us/webinar/regist…
CEVR (@tuftscevr) 's Twitter Profile Photo

What does the future hold for the QALY - replacement or revision? Join CEVR for an online health policy seminar led by Chris Sampson, Sr. Principal Economist at Office of Health Economics, to find out. Oct. 2 from 2-3 pm ET. Details and join link here: cevr.tuftsmedicalcenter.org/events/cevr-he…

CEVR (@tuftscevr) 's Twitter Profile Photo

What is/will be the role of #CEA in public policy? Hear from Sarah Emond, Rena Conti, Lou Garrison, Steven Kymes, and Lisa Prosser PhD during Panel 4 at 10/26 Tufts-CEVR / Duke Margolis event. Register now: In-Person: eventbrite.com/e/tufts-cevrdu… Webinar: wellforce.zoom.us/webinar/regist…

What is/will be the role of #CEA in public policy? Hear from <a href="/sarahkemond/">Sarah Emond</a>, <a href="/contirena1/">Rena Conti</a>, <a href="/ProfLouGarrison/">Lou Garrison</a>, Steven Kymes, and <a href="/laprosser/">Lisa Prosser PhD</a> during Panel 4 at 10/26 Tufts-CEVR / Duke Margolis event.

Register now:

In-Person: eventbrite.com/e/tufts-cevrdu…

Webinar: wellforce.zoom.us/webinar/regist…
CEVR (@tuftscevr) 's Twitter Profile Photo

Join us in Las Vegas for #AMCPNexus 2024 for 2 educational sessions by James Chambers and Molly Beinfeld's presentation of Fariel LaMountain's Platinum Ribbon-winning research on adalimumab product coverage. A full list of CEVR participation can be found here: cevr.tuftsmedicalcenter.org/news/spec-part…

Join us in Las Vegas for #AMCPNexus 2024 for 2 educational sessions by <a href="/jchambers241/">James Chambers</a> and <a href="/mollytoba/">Molly Beinfeld</a>'s presentation of Fariel LaMountain's Platinum Ribbon-winning research on adalimumab product coverage.

A full list of CEVR participation can be found here: cevr.tuftsmedicalcenter.org/news/spec-part…
CEVR (@tuftscevr) 's Twitter Profile Photo

We are pleased to announce that Brian Reid, a nationally-recognized expert in prescription drug policy and communications, has joined CEVR as a Senior Fellow. Brian's work w/ CEVR to focus on drug policy, IRA impacts, PBM effects on cost/access. More at: cevr.tuftsmedicalcenter.org/news/brian-rei…

We are pleased to announce that <a href="/brianreid/">Brian Reid</a>, a nationally-recognized expert in prescription drug policy and communications, has joined CEVR as a Senior Fellow.  Brian's work w/ CEVR to focus on drug policy, IRA impacts, PBM effects on cost/access.

More at: cevr.tuftsmedicalcenter.org/news/brian-rei…
CEVR (@tuftscevr) 's Twitter Profile Photo

What does the future hold for CEA? Hear from experts Davene R. Wright, PhD, Fernando Alarid-Escudero, @nlcrossnohere, and David Kim during Panel 5 at 10/26 Tufts-CEVR / Duke Margolis event. Register now: In-person: eventbrite.com/e/tufts-cevrdu… Webinar: wellforce.zoom.us/webinar/regist…

What does the future hold for CEA?  Hear from experts <a href="/WrightCensored/">Davene R. Wright, PhD</a>, <a href="/feralaes/">Fernando Alarid-Escudero</a>, @nlcrossnohere, and David Kim during Panel 5 at 10/26 Tufts-CEVR / Duke Margolis event.

Register now:

In-person: eventbrite.com/e/tufts-cevrdu…

Webinar: wellforce.zoom.us/webinar/regist…
CEVR (@tuftscevr) 's Twitter Profile Photo

Despite high demand, many low + middle income countries lack capacity to conduct full HTA. Rapid "adaptive HTA" can bridge this gap - new iDSI / Center for Global Development guidelines by CEVR's Dan Ollendorf et al show how. Blog: cgdev.org/blog/rapid-pri…

CEVR (@tuftscevr) 's Twitter Profile Photo

We are thrilled to announce that pioneering #CEA researcher Milton C. Weinstein has joined Panel 2 at the 10/26 Tufts-CEVR / Duke Margolis symposium. Register now! In person: eventbrite.com/e/tufts-cevrdu… Webinar: wellforce.zoom.us/webinar/regist…

We are thrilled to announce that pioneering #CEA researcher Milton C. Weinstein has joined Panel 2 at the 10/26 Tufts-CEVR / Duke Margolis symposium.

Register now!

In person: eventbrite.com/e/tufts-cevrdu…

Webinar: wellforce.zoom.us/webinar/regist…
CEVR (@tuftscevr) 's Twitter Profile Photo

The full agenda for the 10/26 Tufts-CEVR / Duke Margolis event is now available. Visit the CEVR website for download and registration links: cevr.tuftsmedicalcenter.org/events/symposi…. #CEA #heor #healthcare

CEVR (@tuftscevr) 's Twitter Profile Photo

Drug value assessments are important, but economists shouldn't neglect assessment of health services and procedures. Hear perspectives from CEVR's Peter Neumann, Christopher Roebuck, and EBRI's Paul Fronstin during Oct. 31 public webinar. Register now: wellforce.zoom.us/webinar/regist…

Drug value assessments are important, but economists shouldn't neglect assessment of health services and procedures.

Hear perspectives from CEVR's <a href="/PeterNeumann11/">Peter Neumann</a>, <a href="/RxEconomics/">Christopher Roebuck</a>, and EBRI's <a href="/pfronstin/">Paul Fronstin</a> during Oct. 31 public webinar.

Register now: wellforce.zoom.us/webinar/regist…
CEVR (@tuftscevr) 's Twitter Profile Photo

Last chance to register for our October 31 webinar on the importance of conducting non-drug value assessments! Register here: wellforce.zoom.us/webinar/regist…

CEVR (@tuftscevr) 's Twitter Profile Photo

A cost-effective treatment for #Alzheimers would improve US population health and health equity. Read the new distributional CEA by CEVR and Genentech for data-driven insights on policies to further mitigate disparities. jamanetwork.com/journals/jaman…

CEVR (@tuftscevr) 's Twitter Profile Photo

CEVR is now accepting nominations for the 7th annual "CEA Paper of the Year" award. New this year: a second award for best application of the CEA Registry. Submissions due Jan. 31, 2025. Papers must be published in 2024. Prize: $500 Details: cevr.tuftsmedicalcenter.org/news/call-for-…

CEVR (@tuftscevr) 's Twitter Profile Photo

What is the outlook for US payer coverage of specialty therapies in 2025? Expect more utilization management on pricey therapies. For more insights, register for CEVR's December 4 webinar led by James Chambers here: wellforce.zoom.us/webinar/regist…

CEVR (@tuftscevr) 's Twitter Profile Photo

Calling all health economists! The Tufts-CEVR Cost-Effectiveness Analysis Paper of the Year Contest is back! Submit your CEA for a chance to win $500. Deadline: January 31, 2024. Don't miss out! Learn more & apply: cevr.tuftsmedicalcenter.org/news/call-for-… #HEOR #CEA

CEVR (@tuftscevr) 's Twitter Profile Photo

Attention health economists! The Tufts-CEVR Cost-Effectiveness Analysis Paper of the Year Award is open for submissions. Show us your groundbreaking work in CEA and you could win a $500 prize! Submit by January 31, 2025. Apply now: tinyurl.com/yskfm9us #HEOR #CEA